U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669935) titled 'Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study' on June 21.
Brief Summary: ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterventional observational cohort study of nulliparous singleton pregnant women to evaluate biomarkers from blood and ocular imaging for prediction of pregnancy complications [i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)] and risk of adverse outcomes.
Study Start Date: July 30
Study Type: OBSERVATIONAL
Condition:
GDM
Preterm Preeclampsia
Preeclampsia
Fetal Growth Restriction (FGR)
Pregnancy Complicati...